Ibandronic Acid: Clinical Trials

25 trials of Ibandronic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 4 terminated, 2 unknown, 1 withdrawn. 25 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 325Completed 18, Terminated 4, Unknown 2, Withdrawn 1
Phase 22Completed 1, Unknown 1

Follow Ibandronic Acid: new trials by email Literature Review of Ibandronic Acid trials Research Report on Ibandronic Acid

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis
ibandronate, Placebo - Aseptic Hip Necrosis, Hip Necrosis
Phase 3TerminatedBrigitte Jolles, MD82014-06-012017-05-17
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Test group, Reference group - Postmenopausal Women With Osteoporosis
Phase 3CompletedAlvogen Korea2012011-12-012016-11-01
A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis
Phase 3CompletedHoffmann-La Roche412011-04-012015-08-13
A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates
Ibandronate, Denosumab - Postmenopausal Osteoporosis
Phase 3CompletedAmgen8332009-07-012013-02-11
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
Ibandronate, Vitamin Supplements - Hematological Malignancies
Phase 3CompletedM.D. Anderson Cancer Center782008-12-092018-09-13
PTH & Ibandronate Combination Study (PICS)
PTH(1-84), Ibandronate, Placebo injection - Osteoporosis
Phase 2 / Phase 3CompletedUniversity of California, San Francisco442008-05-012013-11-05
BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.
Placebo, ibandronate [Bonviva/Boniva] - Osteoporosis
Phase 3CompletedHoffmann-La Roche682007-06-012016-03-02
Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis
ibandronic acid 0.5mg, RIS placebo, 1.0mg ibandronic acid - Primary Osteoporosis
Phase 3CompletedChugai Pharmaceutical12652007-03-012012-08-02
The Effect Of Oral Ibandronate In Male Osteoporosis
Ibandronate, placebo - Male Osteoporosis
Phase 3CompletedHoffmann-La Roche1352007-01-012009-12-21
Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.
Placebo, Ibandronate - Renal Transplant
Phase 2 / Phase 3UnknownSmerud Medical Research International AS1302007-01-012010-03-24
A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease
Ibandronate - Pain; Bone Neoplasms; Neoplasm Metastasis
Phase 3CompletedHoffmann-La Roche972006-12-012016-11-02
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
Ibandronate - Post-Menopausal Osteoporosis
Phase 3CompletedHoffmann-La Roche6772006-12-012016-10-28
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
ibandronate, zoledronate, quality-of-life assessment - Breast Cancer, Hypercalcemia of Malignancy
Phase 3WithdrawnSWOG Cancer Research Network2006-05-012013-11-13
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
Ibandronate, Zoledronate - Multiple Myeloma
Phase 3TerminatedHoffmann-La Roche892006-02-012016-07-22
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
ibandronate sodium, zoledronic acid, Zolendronic Acid - Breast Cancer, Hypercalcemia of Malignancy
Phase 3UnknownWales Cancer Trials Unit14042006-01-012013-03-13
A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer
Ibandronate - Pain; Bone Neoplasms; Neoplasm Metastasis
Phase 3CompletedHoffmann-La Roche3342006-01-012016-03-23
A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain
ibandronate [Bondronat], zoledronic acid - Pain, Bone Neoplasm
Phase 3TerminatedHoffmann-La Roche962005-08-012017-08-16
A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
ibandronate [Bondronat], zoledronic acid - Pain, Bone Neoplasm
Phase 3TerminatedHoffmann-La Roche1632005-07-012017-08-16
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
clodronate disodium, ibandronate sodium, zoledronic acid - Breast Cancer
Phase 3CompletedSWOG Cancer Research Network60972005-07-012021-07-02
Study of Investigational Drug in Osteoporosis (MK-0217-908)
Placebo, ibandronate - Postmenopausal Osteoporosis
Phase 3CompletedOrganon and Co2032004-12-012022-02-02

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Neoplasm Metastasis (7)  ·  Osteoporosis, Postmenopausal (6)  ·  Pain (6)  ·  Osteoporosis (5)  ·  Bone Neoplasms (4)  ·  Breast Neoplasms (4)  ·  Humoral Hypercalcemia Of Malignancy (2)  ·  Bone Diseases, Metabolic (1)  ·  Breast Neoplasms, Male (1)  ·  Hematologic Neoplasms (1)  ·  Multiple Myeloma (1)  ·  Prostatic Neoplasms (1)

Sponsors

Hoffmann-La Roche (12)  ·  SWOG Cancer Research Network (2)  ·  Alvogen Korea (1)  ·  Amgen (1)  ·  Brigitte Jolles, MD (1)  ·  Cancer Research UK (1)  ·  Chugai Pharmaceutical (1)  ·  GBG Forschungs GmbH (1)  ·  M.D. Anderson Cancer Center (1)  ·  Organon and Co (1)  ·  Smerud Medical Research International AS (1)  ·  University of California, San Francisco (1)  ·  Wales Cancer Trials Unit (1)

Countries

United States (7)  ·  France (6)  ·  Germany (6)  ·  United Kingdom (6)  ·  Australia (4)  ·  Hungary (4)  ·  Italy (4)  ·  Mexico (4)  ·  Poland (4)  ·  Switzerland (4)  ·  Belgium (3)  ·  Canada (3)  ·  Norway (3)  ·  Argentina (2)  ·  Bosnia and Herzegovina (2)

Top investigators

Alexander H Paterson, MD, FRCP (1)  ·  Carla I. Falkson, MD (1)  ·  Dawn Hershman, MD (1)  ·  Dennis M. Black, PhD (1)  ·  Elizabeth C. Dees, MD (1)  ·  Heather Purnell (1)  ·  Huifang Lu, MD, PHD (1)  ·  James N. Ingle, MD (1)  ·  Julie R. Gralow, MD (1)  ·  Katherine Monson (1)  ·  Kathy S. Albain, MD (1)  ·  Knut T Smerud, MSc (1)

Results publications

PMID 21975558, PMID 22791766, PMID 23589163, PMID 23812464, PMID 24332514, PMID 28274254, PMID 31776637, PMID 32929540, PMID 34037241, PMID 37797387, PMID 38979716, PMID 39588131

NIH funding

2005 (1), U10CA037429 (1)